Financial toxicity from newly approved second-/third-line agents in metastatic urothelial carcinoma
File(s)BJU-2022-0414.R1_Proof_hi.pdf (282.6 KB)
Accepted version
Author(s)
Benjamin, David J
Lythgoe, Mark
Rezazadeh, Arash
Type
Journal Article
Date Issued
2023-03-23
Date Acceptance
2023-03-02
Citation
BJU International, 2023, 131 (6), pp.691-693
ISSN
1464-4096
Publisher
Wiley
Start Page
691
End Page
693
Journal / Book Title
BJU International
Volume
131
Issue
6
Copyright Statement
Copyright © 2023 Owner. This is the peer reviewed version of the following article: Financial toxicity from newly approved second-/third-line agents in metastatic urothelial carcinoma, which has been published in final form at https://doi.org/10.1111/bju.16003. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
Identifier
https://bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bju.16003?af=R
Publication Status
Published
Date Publish Online
2023-03-06